Current investigations into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are revealing significant outcomes in managing excess mass and type second-type diabetes. Animal data suggest a unique mechanism https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/